Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD-Reference-Cited by-同舟云学术

Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD

Published:2014-03-12 Issue:1 Volume:14 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Singh Dave,Nicolini Gabriele,Bindi Eddi,Corradi Massimo,Guastalla Daniele,Kampschulte Jorg,Pierzchała Władysław,Sayiner Abdullah,Szilasi Mária,Terzano Claudio,Vestbo Jørgen

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/article/10.1186/1471-2466-14-43/fulltext.html

Reference41 articles.

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. 2013, 187 (4): 347-365. 10.1164/rccm.201204-0596PP. 10.1164/rccm.201204-0596PP

2. Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, Ostinelli J: Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011, 37 (2): 264-272. 10.1183/09031936.00051110.

3. Dong YH, Lin HH, Shau WY, Wu YC, Chang CH, Lai MS: Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax. 2013, 68 (1): 48-56. 10.1136/thoraxjnl-2012-201926.

4. Barnes PJ: Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J. 2002, 19: 182-191. 10.1183/09031936.02.00283202.

5. Caramori G, Ito K, Papi A, Adcock IM: Interactions between long-acting β2 agonists and glucocorticoids. Drug Discov Today Ther Strateg. 2006, 3: 261-268.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in inhaler therapy for asthma and chronic obstructive pulmonary disease: a comprehensive review of Fostair™ and Trimbow™;Journal of Pharmacy and Pharmacology;2024-07-02

2. New Perspectives in Pharmacological Therapy for COPD: Phenotype Classification and Corticosteroids with Bronchodilators;A Compendium of Chronic Obstructive Pulmonary Disease;2023-02-08

3. Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population;Pulmonary Pharmacology & Therapeutics;2022-12

4. Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD;Lung India;2022

5. Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution;Therapeutic Advances in Respiratory Disease;2022-01